par Kaye, S B;Piccart-Gebhart, Martine 
;Aapro, Matti;Francis, P;Kavanagh, J
Référence European journal of cancer, 33, 13, page (2167-2170)
Publication Publié, 1997-11
;Aapro, Matti;Francis, P;Kavanagh, JRéférence European journal of cancer, 33, 13, page (2167-2170)
Publication Publié, 1997-11
Article révisé par les pairs
| Titre: |
|
| Auteur: | Kaye, S B; Piccart-Gebhart, Martine; Aapro, Matti; Francis, P; Kavanagh, J |
| Informations sur la publication: | European journal of cancer, 33, 13, page (2167-2170) |
| Statut de publication: | Publié, 1997-11 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Agents, Phytogenic -- adverse effects | |
| Antineoplastic Agents, Phytogenic -- therapeutic use | |
| CA-125 Antigen -- analysis | |
| Clinical Trials, Phase II as Topic | |
| Female | |
| Humans | |
| Middle Aged | |
| Ovarian Neoplasms -- drug therapy | |
| Paclitaxel -- adverse effects | |
| Paclitaxel -- analogs & derivatives | |
| Paclitaxel -- therapeutic use | |
| Taxoids | |
| Treatment Outcome | |
| Tumor Markers, Biological -- analysis | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:pii/S0959804997003638 | |
| info:pmid/9470802 |
